Furthermore, the concordance rate of KRAS mutation status between the primary CRC tumor and its corresponding metastases is high, supporting the notion that these mutations are acquired before the dissemination of the tumor cells to distant organs [43]. The gene discussed is KRAS; the disease is colorectal carcinoma.